74 related articles for article (PubMed ID: 33668213)
1. Construction of Boronophenylalanine-Loaded Biodegradable Periodic Mesoporous Organosilica Nanoparticles for BNCT Cancer Therapy.
Tamanoi F; Chinnathambi S; Laird M; Komatsu A; Birault A; Takata T; Doan TL; Mai NXD; Raitano A; Morrison K; Suzuki M; Matsumoto K
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668213
[TBL] [Abstract][Full Text] [Related]
2. Biodegradable Periodic Mesoporous Organosilica (BPMO) Loaded with Daunorubicin: A Promising Nanoparticle-Based Anticancer Drug.
Mai NXD; Birault A; Matsumoto K; Ta HKT; Intasa-Ard SG; Morrison K; Thang PB; Doan TLH; Tamanoi F
ChemMedChem; 2020 Apr; 15(7):593-599. PubMed ID: 32020745
[TBL] [Abstract][Full Text] [Related]
3. Assessing the effectiveness of fluorinated and α-methylated 3-boronophenylalanine for improved tumor-specific boron delivery in boron neutron capture therapy.
Hirano F; Kondo N; Murata Y; Sudani A; Temma T
Bioorg Chem; 2024 Jan; 142():106940. PubMed ID: 37939508
[TBL] [Abstract][Full Text] [Related]
4. Recent Development to Explore the Use of Biodegradable Periodic Mesoporous Organosilica (BPMO) Nanomaterials for Cancer Therapy.
Chinnathambi S; Tamanoi F
Pharmaceutics; 2020 Sep; 12(9):. PubMed ID: 32961990
[TBL] [Abstract][Full Text] [Related]
5. Boron-Containing Mesoporous Silica Nanoparticles with Effective Delivery and Targeting of Liver Cancer Cells for Boron Neutron Capture Therapy.
Tang H; Wang Z; Hao H; Luo W; Yang J; Li M; Yang M; Chen Z; Yan R; Li H; Hu F; Liang H; Liu Q; Lv L; Zhang J; Su W; Chen R; Chen K; Chang YN; Wang M; Zheng L; Feng X; Li J; Xing G
ACS Appl Mater Interfaces; 2024 Apr; ():. PubMed ID: 38686647
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the Impact of L-Phenylalanine and L-Tyrosine Pre-Treatment on the Uptake of 4-Borono-L-Phenylalanine in Cancerous and Normal Cells Using an Analytical Approach Based on SC-ICP-MS.
Balcer E; Giebułtowicz J; Sochacka M; Ruszczyńska A; Muszyńska M; Bulska E
Molecules; 2023 Sep; 28(18):. PubMed ID: 37764328
[TBL] [Abstract][Full Text] [Related]
7. 4-Iodobenzonitrile as a fluorogenic derivatization reagent for chromatographic analysis of L-p-boronophenylalanine in whole blood samples using Suzuki coupling reaction.
Fukuda T; Kishikawa N; El-Maghrabey M; Nakamura S; Ohba Y; Kawakami S; Wada M; Kuroda N
Anal Chim Acta; 2024 Jul; 1313():342700. PubMed ID: 38862203
[TBL] [Abstract][Full Text] [Related]
8. Modular Synthetic Approach to Carboranyl‒Biomolecules Conjugates.
Kellert M; Friedrichs JJ; Ullrich NA; Feinhals A; Tepper J; Lönnecke P; Hey-Hawkins E
Molecules; 2021 Apr; 26(7):. PubMed ID: 33916755
[TBL] [Abstract][Full Text] [Related]
9. REMOVED: Boron neutron capture therapy (BNCT) for glioblastoma multiforme: A phase 2 study evaluating a prolonged high dose of boronophenylalanine (BPA).
Henriksson R; Capala J; H-Stenstam B; Michanek A; Lindahl SK; Salford L; Franzén L; Blomquist E; Westlin JE; Bergenheim AT
Radiother Oncol; 2006 May; ():150-157. PubMed ID: 16698096
[TBL] [Abstract][Full Text] [Related]
10. Mesoporous silica/organosilica nanoparticles for cancer immunotherapy.
Theivendran S; Lazarev S; Yu C
Exploration (Beijing); 2023 Jun; 3(3):20220086. PubMed ID: 37933387
[TBL] [Abstract][Full Text] [Related]
11. Internal Functionalization and Surface Modification of Vinylsilsesquioxane Nanoparticles.
Brozek EM; Zharov I
Chem Mater; 2009; 21(8):1451-1456. PubMed ID: 20046982
[TBL] [Abstract][Full Text] [Related]
12. Oral Drug Delivery Systems Based on Ordered Mesoporous Silica Nanoparticles for Modulating the Release of Aprepitant.
Christoforidou T; Giasafaki D; Andriotis EG; Bouropoulos N; Theodoroula NF; Vizirianakis IS; Steriotis T; Charalambopoulou G; Fatouros DG
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672949
[TBL] [Abstract][Full Text] [Related]
13. Optimizing Boron Neutron Capture Therapy (BNCT) to Treat Cancer: An Updated Review on the Latest Developments on Boron Compounds and Strategies.
Monti Hughes A; Hu N
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627119
[TBL] [Abstract][Full Text] [Related]
14. Organosilica nanoparticles containing sodium borocaptate (BSH) provide new prospects for boron neutron capture therapy (BNCT): efficient cellular uptake and enhanced BNCT efficacy.
Laird M; Matsumoto K; Higashi Y; Komatsu A; Raitano A; Morrison K; Suzuki M; Tamanoi F
Nanoscale Adv; 2023 May; 5(9):2537-2546. PubMed ID: 37143818
[TBL] [Abstract][Full Text] [Related]
15. Recent Development of Radiofluorination of Boron Agents for Boron Neutron Capture Therapy of Tumor: Creation of
Deng JP; Yu CS
Pharmaceuticals (Basel); 2023 Jan; 16(1):. PubMed ID: 36678590
[TBL] [Abstract][Full Text] [Related]
16. Boron Vehiculating Nanosystems for Neutron Capture Therapy in Cancer Treatment.
Ailuno G; Balboni A; Caviglioli G; Lai F; Barbieri F; Dellacasagrande I; Florio T; Baldassari S
Cells; 2022 Dec; 11(24):. PubMed ID: 36552793
[TBL] [Abstract][Full Text] [Related]
17. Using
Tabbakh F; Hosmane NS; Tajudin SM; Ghorashi AH; Morshedian N
Sci Rep; 2022 Oct; 12(1):17404. PubMed ID: 36258012
[TBL] [Abstract][Full Text] [Related]
18. Tumor Accumulation of PIP-Based KRAS Inhibitor KR12 Evaluated by the Use of a Simple, Versatile Chicken Egg Tumor Model.
Higashi Y; Ikeda S; Matsumoto K; Satoh S; Komatsu A; Sugiyama H; Tamanoi F
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205697
[TBL] [Abstract][Full Text] [Related]
19. The Physical Chemistry and Chemical Physics (PCCP) Section of the
Mikhailov OV
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008667
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
